Skip to main content
. 2024 Mar 21;12(3):702. doi: 10.3390/biomedicines12030702
FGIDs functional gastrointestinal disorders
IBDs inflammatory bowel diseases
UC ulcerative colitis
CD Chron’s disease
HP Helicobacter pylori
IBS irritable bowel syndrome
FD functional dyspepsia
DCs dendritic cells
TNF-α tumor necrosis factor-α
ILs interleukins
IFNs interferons
Treg cells regulatory T cells
Teff cells effector T cells
NETs neutrophil extracellular traps
ROS reactive oxygen species
LDGs low-density granulocytes
INFIs type I interferons
PRRs pattern recognition receptors
PAMPs pathogen-associated molecular patterns
DAMPs danger-associated molecular patterns
NK cells natural killer cells
Th1 cells T helper cells type 1
T2D type 2 diabetes
CVD cardiovascular diseases
TGF-β transforming growth factor-β
naAbs natural antibodies
HPA hypothalamic-pituitary-adrenal
ILC1s innate lymphoid cells type 1
ILC2s innate lymphoid type 2 cells
LPSs lipopolysaccharides
SCFAs short-chain fatty acids
BCFAs branched-chain amino acids
IgA immunolobulin A
FDCs follicular dendritic cells
Thf cells follicular Th cells
CNS central nervous system
PDS postprandial distress syndrome
EPS epigastric pain syndrome
ENS enteric nervous system
ANS autonomic nervous system
ECCs enterochromaffin cells
5-HT 5-hydroxytryptamine
TPH1 tryptophan hydroxylase 1
PI-IBS post-infection irritable bowel syndrome
EoE eosinophilic esophagitis
Th17 T-helper 17
TSLP thymic stromal lymphoprotein
iNKT cells invariant natural killer T cells
ILC3s innate lymphoid type 3 cells
CRF corticotropin-releasing factor
CRP C-reactive protein
LBP lipopolysaccharide binding protein
IFABP intestinal fatty acid binding protein